Israel Innovation Authority

RepAir is at the forefront of advancing a carbon-negative future through its innovative carbon removal technology. The company has developed an electrochemical device that effectively captures carbon dioxide from the atmosphere by utilizing electricity. This process involves drawing in ambient air and passing it through a specialized membrane that selectively separates carbon dioxide, allowing clean air to be released back into the environment. RepAir's fully electric and zero-heat technology is designed for large-scale deployment, emphasizing environmental sustainability while minimizing energy consumption. Importantly, the system operates without the use of liquids, solvents, or hazardous materials, producing no waste and supporting clients in reducing their carbon footprints and energy costs.

Brain.space is a data company focused on brain mapping, aiming to support researchers, medical professionals, and software developers in interpreting and analyzing brain activity. The company offers a comprehensive and affordable technology stack that includes noninvasive brain activity mapping and monitoring, along with validated big data interpretation and insights. This platform enables users to develop innovative products and services that leverage brain activity data, facilitating advancements in various fields related to neuroscience and mental health.

nT-Tao is building a compact fusion reactor that will generate 10-20 MW of electricity. The reactor is highly scalable and will be about the size of a shipping container, ensuring clean fusion energy wherever needed. The reactor’s scalability and affordability will make it suitable for various power needs, ranging from industrial and manufacturing facilities to small towns and off-grid locations. This scalability coupled with the ability for rapid deployment, positions nT-Tao’s reactor as a versatile and adaptable fusion energy solution. nT-Tao’s unique solution relies on a proprietary plasma heating method which is expected to reach 1000 times higher density than other fusion reactors, thereby making its fusion reaction 1 million times more effective. nT-Tao’s ability for quick development iterations and its groundbreaking approach, dramatically reduces the size, cost, and complexity of fusion energy reactors. Co-founded by Oded Gour-Lavie, Doron Weinfeld, and Boaz Weinfeld, nT-Tao’s mission is to develop a unique nuclear fusion technology that will enable the world to transition towards a cleaner, decarbonized, sustainable, and advanced future.

IBI-Ag is a biotechnology company dedicated to developing innovative bioinsecticides that provide environmentally friendly pest management solutions for farmers. The company focuses on creating natural single-domain antibody insecticides designed to enhance crop production while ensuring the safety of farm workers, consumers, and the environment. By utilizing advanced technology and fermentation processes, IBI-Ag offers efficient and selective pest control solutions that lower agricultural costs. The company's platform is built on thorough testing and extensive learning, allowing farmers to access customized biological pest control strategies that meet their specific needs. Through its commitment to sustainable practices, IBI-Ag aims to revolutionize the agricultural landscape by promoting safer and more effective methods of insect management.

Promise Bio is a biotechnology company dedicated to advancing precision medicine for autoimmune diseases. It leverages epiproteomic analysis, a cutting-edge technique that examines protein modifications, to gain insights into disease mechanisms. The company's core technology is a cloud-based AI platform that processes standard mass-spectrometry data, enabling comprehensive analysis and discovery of biomarkers. This innovative approach aims to optimize personalized treatment plans, enhance the quality of care, and make chronic disease management more affordable and effective.

MICA is a medical technology company focused on improving breast cancer diagnosis through artificial intelligence. It has developed a system that aids radiologists in the analysis and comparison of mammography images. By offering a range of products designed for mammogram analysis, image comparison, and medical records management, MICA aims to enhance the accuracy of breast cancer detection. The company's tools enable medical professionals to facilitate early diagnosis and treatment, ultimately contributing to a reduction in breast cancer incidence.

Airobotics offers a fully automated solution for collecting aerial data, catering to government, industrial, and commercial sectors. The company manufactures autonomous unmanned aerial drones that facilitate automated data capture and analysis. Airobotics' technology is utilized for a variety of applications, including real-time video monitoring, disaster assessments, compliance audits, land investigations, inspections, surveillance, progress tracking, and survey services. By providing these comprehensive capabilities, Airobotics enables organizations to gain valuable insights and improve operational efficiency.

Eretz Angels supports technology startups in Israel's outskirts at the start of their journey.

Lidwave is a developer of advanced 3D sensing technology that addresses significant challenges in traditional LiDAR and radar systems. By utilizing a novel approach based on finite coherence ranging, Lidwave's solution offers four-dimensional sensing capabilities that enhance automation across various sectors, including autonomous vehicles, industrial robotics, and smart cities. The technology leverages new coherent properties of light, providing superior Doppler and depth information that improves decision-making processes. This innovative approach not only overcomes the limitations of existing sensing methods but also positions Lidwave as a leader in the development of disruptive sensing technologies, paving the way for smarter and safer applications in numerous industries.

Lavie Bio specializes in the development of bacterial compositions and microbiome-based products aimed at enhancing agricultural practices. The company's offerings include bio-stimulants and bio-pesticides that can be applied as sprays on plants, used to coat seeds, or integrated into soil. These products are designed to improve the quality and health attributes of crops by utilizing natural, biological sources, including various microbial and biochemical components. Lavie Bio focuses on providing agricultural businesses with innovative ag-biological technologies to support sustainable farming and improve plant features.

SolidT is at the forefront of innovation, pioneering a cutting-edge decentralized temperature control system based on solid-state technology. This revolutionary system empowers precise regulation of temperature for various components, such as batteries, battery cells, modules, high-frequency processors, displays, interiors, and more – all achieved without the need for traditional compressors and their associated systems. SolidT's groundbreaking technology promises to streamline automotive temperature control systems by simplifying complexity, shedding excess weight, and enhancing reliability. This innovation not only elevates efficiency and precision but also significantly slashes manufacturing costs and operational expenses. SolidT's disruptive system finds applications across diverse industries, including automotive, electronics, and high-energy devices, making it a game-changer for temperature management solutions.

TruLeaf Medical is a developer of user-friendly Transcatheter Mitral Valve Replacement (TMVR) solution.

IR-MED Ltd. is a medical device company based in Rosh Pinna, Israel, specializing in infrared light-based diagnostic systems. Founded in 2012, the company utilizes advanced technologies such as big data and machine learning to enhance its diagnostic capabilities. IR-MED focuses on developing continuous and real-time monitoring systems that can detect and measure various substances and pharmaceuticals in the blood. Additionally, its technology allows for the assessment of fluid concentrations on surfaces and beneath thin tissues, facilitating the identification and characterization of diverse medical lesions and pathological processes in humans.

OCON Healthcare, also known as OCON Medical Ltd., specializes in developing and manufacturing innovative women's health products centered around its proprietary Intra Uterine Ball (IUB) platform. Key offerings include the IUB Ballerine, a hormone-free, copper-based intrauterine contraceptive effective for five years, and the OCON SEAD, which is currently undergoing Phase II clinical studies for treating abnormal uterine bleeding. The IUB platform, constructed from a super-elastic alloy, serves as an effective carrier for various therapeutic substances targeting conditions such as heavy menstrual bleeding, fibroids, and infertility. The company distributes its contraceptive products primarily in Europe, South Africa, and Israel. Founded in 2011, OCON Healthcare operates from its headquarters in Modi'in-Maccabim-Re'ut, Israel, and maintains an additional office in Zürich, Switzerland.

TEClub VC is an investment firm for mega angels that invests in breakthrough technologies at early stages through a smart and selective investment platform. They focus on creating unicorn companies and venture creation models.

Eight Two Hundred Angels is an investment firm, They assist in promoting the companies in which they invest, attract investors, and qualify investors interested in investing in innovative technologies and high-risk investments.

Nugen Clean Energy specializes in off-grid electric vehicle (EV) charging systems. Their innovative technology uses a solid-state hydrogen compound to safely generate and utilize hydrogen on-site and on-demand, ensuring a reliable and sustainable power source even in remote locations. This enhances grid capacity and provides uninterrupted charging, making EV charging infrastructure more scalable and dependable.

AccuLine is a digital healthcare company focused on preventing heart attacks by offering innovative solutions for early detection of coronary artery disease (CAD). The company is developing CORA, a non-invasive examination technology that provides a smart, accurate, and user-friendly alternative to traditional stress tests. By streamlining the detection process, CORA enables healthcare providers to identify CAD more swiftly and cost-effectively, ultimately aiming to save millions of lives worldwide through timely intervention.

Soltell specializes in Industrial IoT-powered automation for the management of rooftop solar photovoltaic (PV) systems. The company's smart solar management platform allows for cost-effective supervision of distributed solar energy fleets, connecting solar service providers, commercial property owners, and smart city initiatives. Utilizing advanced process automation and proprietary sensorless weather measurement technology, Soltell enhances transparency and efficiency in the operation of rooftop solar PV installations. Its platform is designed to support a range of inverters and data loggers, making it compatible with both new and existing PV systems. By offering predictive maintenance capabilities, Soltell aids clients in optimizing the management and operation of decentralized solar energy systems, ultimately facilitating a transition to more resilient and efficient energy generation in urban settings.

Sequentify is a biotechnology company that develops innovative solutions for targeted DNA sequencing applications, including cancer diagnostics, carrier screening, and COVID-19 surveillance. By integrating synthetic biology with artificial intelligence software, the company offers alternative library-preparation methods that facilitate rapid and cost-effective genome sequencing. This technology empowers researchers to conduct genomic diagnostics and therapeutics on a large scale, thus enhancing the efficiency and accessibility of genomic analysis in various health-related fields.

FireDome's revolutionary wildfire defense system takes a two-tiered strategy. First, a mechanical launcher quickly deploys a protective barrier to impede the direct route of advancing wildfires. Second, the system actively detects and promptly extinguishes spot fires created by airborne embers that bypass the primary barrier.

Charging Robotics engages in wireless charging solutions.

NurExone Biologic is developing a biological exosome based technology drug platform to treat damage in the Central Nerve System.

Airobotics offers a fully automated solution for collecting aerial data, catering to government, industrial, and commercial sectors. The company manufactures autonomous unmanned aerial drones that facilitate automated data capture and analysis. Airobotics' technology is utilized for a variety of applications, including real-time video monitoring, disaster assessments, compliance audits, land investigations, inspections, surveillance, progress tracking, and survey services. By providing these comprehensive capabilities, Airobotics enables organizations to gain valuable insights and improve operational efficiency.

CODA is a cloud-based AI platform that translates spoken language into sign language and provides the deaf community with easier access to video content in their preferred language.

Maris-Tech is a global leader in video and AI-based edge computing technology, pioneering intelligent video transmission solutions that conquer complex encoding-decoding challenges. Our miniature, lightweight, and low-power products deliver high-performance capabilities including raw data processing, seamless transfer, advanced image processing, and AI-driven analytics. Founded by Israel technology sector veterans, Maris-Tech serves leading manufacturers worldwide in defense, aerospace, Intelligence gathering, homeland security (HLS) and communication industries worldwide. We’re pushing the boundaries of video transmission and edge computing, driving innovation in mission-critical applications across commercial and defense sectors.

Microbot Medical is a medical device company based in Hingham, Massachusetts, founded in 2010. It specializes in developing micro-robotic technologies for minimally invasive surgery. The company's key products include the Self Cleaning Shunt (SCS) for treating hydrocephalus and normal pressure hydrocephalus, TipCAT, a self-propelling endoscope initially designed for colonoscopy procedures, and Liberty, a combination of guidewire and microcatheter technologies for endoluminal surgery. Microbot Medical aims to enhance surgical outcomes by providing less invasive and more precise solutions, with 37 issued/allowed patents and 15 patent applications pending worldwide.

Pashoot Robotics specializes in contextual robotics for the manufacturing sector, focusing on the flexible deployment of robotic arms. The company has developed automation software that allows robots to learn and adapt to their environments, moving beyond simple pre-programmed tasks. This innovative approach democratizes robotic automation, enabling manufacturers to enhance productivity and maintain competitiveness in their respective industries. By integrating human-like learning capabilities into production lines, Pashoot Robotics aims to transform traditional manufacturing practices and improve operational efficiency.

SolidT is at the forefront of innovation, pioneering a cutting-edge decentralized temperature control system based on solid-state technology. This revolutionary system empowers precise regulation of temperature for various components, such as batteries, battery cells, modules, high-frequency processors, displays, interiors, and more – all achieved without the need for traditional compressors and their associated systems. SolidT's groundbreaking technology promises to streamline automotive temperature control systems by simplifying complexity, shedding excess weight, and enhancing reliability. This innovation not only elevates efficiency and precision but also significantly slashes manufacturing costs and operational expenses. SolidT's disruptive system finds applications across diverse industries, including automotive, electronics, and high-energy devices, making it a game-changer for temperature management solutions.

Oversight is a developer of a 3D collaborative workspace platform aimed at enhancing decision-making for first responders. The platform integrates advanced AI simulation and real-time data management from various devices, including drones, body cameras, and smartphones. By providing comprehensive situational awareness, Oversight supports emergency response teams in their mission planning and operational efficiency, enabling them to make informed decisions during critical situations.

Navina is a technology company that has developed an AI-driven platform aimed at transforming disorganized patient data into clear and actionable patient portraits. This innovative approach allows physicians to quickly assess complex cases, significantly enhancing the diagnostic process and patient care. By utilizing artificial intelligence and machine learning, Navina's platform organizes essential patient information in a way that is intuitively accessible, ensuring that critical data is easily understood and contextually relevant. This capability not only improves patient wellness but also supports better financial outcomes for healthcare providers and payers. Additionally, Navina collaborates with the American Academy of Family Physicians Innovation Lab, further solidifying its commitment to advancing healthcare through technology.

SuperMeat is an Israeli biotech and food-tech company founded in 2015 and based in Tel Aviv. It specializes in producing cultured meat from chicken cells in a safe, controlled environment, eliminating the need for animal slaughter. This innovative approach to meat production aims to enhance nutritional security and reduce carbon emissions. By growing meat in a sterile setting, SuperMeat ensures that its products are free from antibiotics and the risk of fecal contamination, such as salmonella. The company emphasizes sustainability, as its clean meat production requires significantly fewer resources—99% less land and 90% less water—compared to traditional methods. SuperMeat aspires to transform the meat industry, offering a healthier and more sustainable food source for the future.

VALFIX Medical Ltd, established in 2016 and based in Tel Aviv, Israel, specializes in the design and development of transcatheter solutions for Mitral and Tricuspid valve repair and replacement. Their innovative, minimally-invasive approach combines repair and replacement treatments, providing a viable alternative to open-heart surgery. The company's multi-wire technology enables transcatheter mitral valve repair procedures, aiming to alleviate heart failure symptoms and treat various heart conditions by eliminating mitral regurgitation.

Brevel has developed an innovative cultivation technology focused on the sustainable and cost-effective production of microalgae. Utilizing high-tech, fully automated indoor systems that feature internal illumination, Brevel's approach achieves significant cost reductions and substantially higher yields compared to traditional methods. This advanced technology positions the company to tap into various markets in need of microalgae-derived products, including sustainable food, materials, chemicals, pharmaceuticals, and energy. By unlocking the full potential of microalgae, Brevel aims to create an alternative protein source suitable for mass production, addressing the increasing demand for environmentally friendly solutions across multiple industries.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

AccuLine is a digital healthcare company focused on preventing heart attacks by offering innovative solutions for early detection of coronary artery disease (CAD). The company is developing CORA, a non-invasive examination technology that provides a smart, accurate, and user-friendly alternative to traditional stress tests. By streamlining the detection process, CORA enables healthcare providers to identify CAD more swiftly and cost-effectively, ultimately aiming to save millions of lives worldwide through timely intervention.

Alumor develops solar-powered water purification technology devices based on ultraviolet LED light which can purify any type of surface water, including lakes, rivers, lagoons, and pools.

BeeHero is a company that has developed an innovative beehive technology platform aimed at enhancing crop yields through effective pollination. Utilizing artificial intelligence and machine learning algorithms, the platform employs low-cost sensors to gather data from within beehives. This information helps stimulate optimal productivity during critical pollination periods, assisting farmers in safeguarding their beehives against colony collapse and improving overall pollination efficiency. Founded in 2017 by Itai Kanot, Omer Davidi, and Yuval Regev, BeeHero operates from locations in Tel Aviv and Silicon Valley, with a workforce of 50 employees, including 30 at its research and development center in Israel.

Kipp enables card issuers and merchants to approve more transactions, leading to higher customer satisfaction and greater revenue. Kipp's platform serves and supports issuer banks in optimizing their cards' business, leveraging their relationships with merchants, their willingness to share data and participate in the cost of risk.

IBI-Ag is a biotechnology company dedicated to developing innovative bioinsecticides that provide environmentally friendly pest management solutions for farmers. The company focuses on creating natural single-domain antibody insecticides designed to enhance crop production while ensuring the safety of farm workers, consumers, and the environment. By utilizing advanced technology and fermentation processes, IBI-Ag offers efficient and selective pest control solutions that lower agricultural costs. The company's platform is built on thorough testing and extensive learning, allowing farmers to access customized biological pest control strategies that meet their specific needs. Through its commitment to sustainable practices, IBI-Ag aims to revolutionize the agricultural landscape by promoting safer and more effective methods of insect management.

ViAqua Therapeutics Ltd is an Israeli company founded in 2014 that specializes in developing innovative drugs and therapeutics for the aquaculture industry. The company focuses on creating the first orally administered treatment designed to combat viral diseases affecting aquatic species, particularly shrimp. ViAqua's proprietary platform employs a unique RNAi nanoparticle formulation that triggers a cellular response to disable viral infections. This technology enables the delivery of coated nanoparticles through feed or immersion techniques, enhancing the resistance of aquaculture species against viral epidemics. With a management team experienced in business development and industrial biotechnology, ViAqua aims to improve the health and sustainability of aquaculture practices.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

Spectalix provides a unique solution for brands looking to regain user engagement on their own digital platforms, such as apps and websites, by offering a white-label user-generated content (UGC) platform. This innovative platform utilizes advanced AI video technology, including background replacement and image segmentation, which allows users to create personalized video content featuring themselves in various scenes, such as alongside sports teams or popular musicians. By enabling users to share these clips on social media, Spectalix transforms them into micro-influencers, helping brands enhance their digital presence. Additionally, the platform incorporates an automated moderation mechanism to ensure brand safety of the content created. This approach allows brands to monetize their digital assets while fostering a deeper connection with their audience.

Anicca is a health technology company specializing in mental well-being. It designs and develops a wearable device equipped with a respiration sensor and haptic feedback mechanism. This device, worn on the wrist, monitors and analyzes the user's breathing patterns, providing real-time, gentle vibrations to help regulate stress levels, improve focus, and enhance sleep quality.

Flytrex is the largest drone-based food delivery service in the United States, primarily operating in North Carolina and Texas. The company has successfully fulfilled over 120,000 orders for various partners, including notable chains such as Little Caesars, Papa John's, and El Pollo Loco. Flytrex's service is designed to offer rapid delivery, reducing costs from $10 to $1 per package and cutting delivery times from 20 minutes to under 5. With a strong customer retention rate of 45% after two years and a household penetration of 70% within its service range, the company has garnered significant customer satisfaction, reflected in its high Net Promoter Score of 75. Flytrex employs advanced automated drone technology operated via a cloud-based control system, facilitating efficient deliveries even to hard-to-reach areas while minimizing operational expenses for retailers and delivery companies.

FertilAI is a healthcare company focused on enhancing fertility treatment outcomes through advanced technology. The company has developed an AI-driven platform that streamlines the decision-making process for physicians, thereby improving the success rate of fertility treatments. Its algorithms are integrated into the Fertilane platform, which facilitates efficient communication among clinics, doctors, and patients via specialized applications designed for fertility workflows. Founded by a team of technology experts and leading reproductive endocrinologists in Israel, FertilAI aims to elevate the patient experience and enable clinics to scale their operations effectively.

Soltell specializes in Industrial IoT-powered automation for the management of rooftop solar photovoltaic (PV) systems. The company's smart solar management platform allows for cost-effective supervision of distributed solar energy fleets, connecting solar service providers, commercial property owners, and smart city initiatives. Utilizing advanced process automation and proprietary sensorless weather measurement technology, Soltell enhances transparency and efficiency in the operation of rooftop solar PV installations. Its platform is designed to support a range of inverters and data loggers, making it compatible with both new and existing PV systems. By offering predictive maintenance capabilities, Soltell aids clients in optimizing the management and operation of decentralized solar energy systems, ultimately facilitating a transition to more resilient and efficient energy generation in urban settings.

Baseline Vision specializes in providing a scalable real-time game analytics solution tailored for the net-sports market, with an initial focus on tennis. The company's platform leverages a portable smart-camera device to deliver a range of digital products, including line-calling, performance tracking, on-court gamification, and video feedback. This innovative approach enables tennis players and coaches to analyze past training sessions, monitor their progress, connect with other players, and share their experiences on social media, enhancing their overall training and competitive experience.

DiA Imaging Analysis Ltd. specializes in AI-driven ultrasound analysis technology aimed at enhancing cardiac function diagnostics. Established in 2009 and based in Beersheba, Israel, the company provides a suite of automated tools, including LVivo EF for ejection fraction evaluation, LVivo RV for right ventricle analysis, and LVivo Strain for assessing myocardial strain. These solutions address common challenges faced by clinicians, such as obtaining optimal images and accurately analyzing them for clinical abnormalities. DiA's products, which can be integrated into any ultrasound device or healthcare IT system, also include LVivo SAX for detecting coronary heart disease and LVivo Mobile for mobile ultrasound analysis. The company holds regulatory clearances for its cardiac toolbox and serves a global user base, reflecting its commitment to making ultrasound analysis smarter and more accessible.

XRHealth Ltd. is a medical technology company based in Tel Aviv, Israel, that specializes in developing virtual reality (VR) software solutions for healthcare. Founded in 2016, the company offers an array of products designed to enhance patient care and treatment outcomes. Its offerings include VRPhysio, a platform for virtual physical therapy; VRReliever, which helps manage pain through distraction; VRCogni, aimed at improving motor function in stroke and dementia patients; and VRPsyc, which provides exposure therapy for various mental health disorders. Additionally, VRCoordi is designed to aid coordination recovery in patients with Parkinson's, brain injuries, and autism. By integrating immersive technologies with licensed clinicians and advanced data analytics, XRHealth provides comprehensive telehealth services, allowing patients to access treatment from the comfort of their own homes.

Cymptom provides a security platform designed to proactively measure and manage cyber risk by identifying and mapping potential attack paths before they occur. The platform utilizes agentless data collection technology to continuously visualize viable attack scenarios across both on-premises and cloud environments. By aligning its risk assessment with the MITRE ATT&CK® framework, Cymptom enables organizations to understand and prioritize security gaps in real-time without the need for simulations or interference with existing security measures. This approach offers simple deployment and immediate insights, ensuring continuous cyber resilience and enabling organizations to safeguard their mission-critical assets without disrupting business operations.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

Nobio Ltd. is an Israel-based company that specializes in developing innovative nano-polymer additives designed to protect against microbial infections. Their technology offers a unique, fully-integrated anti-biofilm solution, utilizing potent particles embedded in various materials and products to inhibit biofilm formation indefinitely. Nobio's product line includes a universal bonding agent that provides strong adhesion for dental applications, as well as flowable composites suitable for various restorative procedures. By transforming both implantable and non-implantable devices into biofilm-resistant platforms, Nobio aims to enhance the safety and durability of medical and dental materials through its advanced antimicrobial technology.

BrainStorm Cell Therapeutics Inc. is a biotechnology company focused on developing and commercializing adult stem cell therapies for neurodegenerative diseases. Their proprietary technology, NurOwn, utilizes a patient's own mesenchymal stem cells, which are engineered to produce neurotrophic factors that promote neuronal survival. The company is actively advancing NurOwn through clinical trials for conditions such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Parkinson's disease. Currently, NurOwn is in a Phase III clinical trial for ALS and a Phase II trial for MS, with plans for preclinical studies targeting Parkinson’s disease, Huntington’s disease, and autism spectrum disorder. BrainStorm has partnered with Catalent for the manufacturing of NurOwn, ensuring the production of this autologous cellular therapy. Founded in 2000 and headquartered in New York, BrainStorm Cell Therapeutics was previously known as Golden Hand Resources Inc. before rebranding in 2004.

Indoor Robotics Ltd, founded in 2018 and based in Ramat Gan, Israel, specializes in the design and development of Tando, an AI-powered patrol drone tailored for indoor security and inspection tasks. Tando employs independent AI-based navigation and a patented ceiling docking system, providing real-time coverage and utilizing predictive analysis to reduce false alarms. The drone autonomously collects and analyzes data, promoting consistent quality and enhancing safety. This innovative solution combines robotics with advanced AI capabilities, offering a cost-effective and efficient approach to intelligent indoor monitoring. By collaborating with leaders in the security and smart building sectors, Indoor Robotics aims to transform the landscape of indoor surveillance and inspection through improved area coverage and response times.

Brevel has developed an innovative cultivation technology focused on the sustainable and cost-effective production of microalgae. Utilizing high-tech, fully automated indoor systems that feature internal illumination, Brevel's approach achieves significant cost reductions and substantially higher yields compared to traditional methods. This advanced technology positions the company to tap into various markets in need of microalgae-derived products, including sustainable food, materials, chemicals, pharmaceuticals, and energy. By unlocking the full potential of microalgae, Brevel aims to create an alternative protein source suitable for mass production, addressing the increasing demand for environmentally friendly solutions across multiple industries.

Anicca is a health technology company specializing in mental well-being. It designs and develops a wearable device equipped with a respiration sensor and haptic feedback mechanism. This device, worn on the wrist, monitors and analyzes the user's breathing patterns, providing real-time, gentle vibrations to help regulate stress levels, improve focus, and enhance sleep quality.

Sanolla is a digital healthcare platform focused on creating innovative medical diagnostic solutions for healthcare professionals and patients. The company specializes in AI-powered diagnostic equipment that analyzes previously inaccessible body infrasounds and vital signs, facilitating the early assessment and monitoring of cardiopulmonary conditions. Sanolla's products are designed to be affordable and user-friendly, promoting non-invasive assessments that enable immediate and accurate diagnostic results. This approach not only enhances patient convenience by reducing unnecessary clinic visits but also minimizes the associated risks of exposure to infections, ultimately saving time and healthcare costs.

MedHub-AI specializes in developing deep-learning algorithms for video analysis, aimed at enhancing diagnostic capabilities in medical settings. Its technology integrates into medical video systems, providing precise diagnostic insights and practical guidance, particularly for cardiologists and gastroenterologists. By processing extensive clinical data—both visual and textual—MedHub-AI's solutions support physicians in making informed decisions and improving procedural efficiency. The automated decision support system is designed to streamline cardiac catheterization procedures, reducing the need for invasive supplementary interventions by leveraging image-based software. Overall, MedHub-AI focuses on improving physician performance and health outcomes through sophisticated AI-driven tools.

Greeneye Technology is a company based in Tel-Aviv, Israel, founded in 2017, that focuses on precision agriculture through the use of artificial intelligence. The company has developed a proprietary selective spraying system that transforms conventional sprayers into smart machines capable of detecting weeds and applying herbicides precisely and in real-time. This innovative approach significantly reduces herbicide usage by as much as 90%, moving away from the traditional method of indiscriminate spraying. Greeneye's technology leverages machine learning and computer vision to automate field scouting and optimize herbicide application, providing farmers with valuable insights into their fields. The multidisciplinary team at Greeneye combines expertise in various fields, including agronomy and mechanical engineering, to deliver sustainable solutions that enhance agricultural practices globally.

RenalSense Ltd. is a medical device company based in Jerusalem, Israel, with an additional office in Brookline, Massachusetts. Founded in 2009, the company focuses on developing innovative solutions for real-time renal diagnostics to address the critical issue of acute kidney injury (AKI) in patients, particularly in intensive care settings. Its flagship product, Clarity RMS, is a monitoring system that continuously measures urine flow and automatically transmits real-time data to medical staff, allowing for early detection of changes in renal function. By providing timely alerts regarding fluctuations in urine flow, RenalSense aims to prevent the progression of kidney injury, which is often reliant on early detection. The company's technology seeks to establish new clinical standards, improve patient outcomes, and reduce healthcare costs associated with AKI management.

CathWorks Ltd. is a medical technology company that specializes in enhancing percutaneous coronary intervention (PCI) therapy decisions through its advanced computational science platform. Founded in 2013 and headquartered in Kfar-Saba, Israel, with an additional office in the United States, the company has developed the CathWorks FFRangio, a non-invasive device that provides objective, multi-vessel physiologic measurements. This tool transforms coronary angiography from a subjective visual assessment into an objective decision-making framework based on fractional flow reserve (FFR) metrics. By utilizing sophisticated algorithms to process visual information, CathWorks aims to improve the efficiency of cath lab operations and support healthcare providers in making data-driven clinical decisions.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

Lineage Cell Therapeutics is a clinical-stage biotechnology company headquartered in Carlsbad, California, that specializes in the development and commercialization of innovative cellular therapies aimed at addressing unmet medical needs associated with degenerative diseases. The company’s leading product candidates include OpRegen, designed for the treatment of dry age-related macular degeneration, and OPC1, which targets acute spinal cord injuries. Additionally, Lineage is advancing VAC2, an allogeneic cancer immunotherapy aimed at non-small cell lung cancer. Other notable developments include Renevia, a hyaluronan-based hydrogel for treatment of HIV-associated facial lipoatrophy, and HyStem, a biomaterial for cell retention and delivery. Lineage also explores various therapeutic products for oncology and neurological disorders, alongside research programs focused on vision restoration and demyelination. Established in 1990, the company was formerly known as BioTime, Inc., and underwent a rebranding in August 2019.

OKO specializes in providing crop micro-insurance services aimed at supporting farmers in emerging markets. By leveraging satellite technology, the company assesses risk and develops tailored insurance products that are accessible and affordable for small farmers. OKO utilizes mobile technologies to facilitate the distribution of insurance, collection of premiums, and management of claims, allowing farmers to receive personalized and automated policies directly through their mobile phones. This innovative approach ensures that farmers have financial protection against adverse weather conditions such as droughts and excessive rainfall, enhancing their resilience and security in unpredictable agricultural environments.

Soapy Care Ltd, founded in 2017 and based in Tel Aviv, Israel, specializes in manufacturing IoT-powered hygiene micro-stations that ensure precise dosages of soap and water for handwashing. The company provides smart soap capsules that support regulatory compliance and enhance hygiene practices, addressing significant concerns about compliance, liability, and safety in various environments. Their innovative product turns handwashing into a digital experience, capturing valuable data that can benefit multiple stakeholders. Soapy Care has established a presence in the Indian market and is making its entry into the U.S., which is seen as a key market for expansion. The company has received numerous awards for its groundbreaking impact and operates with a strong team focused on reducing healthcare-associated infections and improving sanitation standards.

FARM INPUT & OUTPUT PRIVATE LIMITED operates a digital marketplace focused on agricultural produce in emerging markets, where internet access for farmers is limited. The company offers a hybrid platform that integrates both digital and SMS-based technologies, allowing farmers to list their crops through an AI-driven SMS chatbot. Buyers can search for available produce by location, time of sale, and quantity using the Farmster app or website. This innovative approach enables farmers to connect with potential buyers even before harvest, facilitating transactions and enhancing the agricultural value chain. By bridging the gap between farmers and buyers, FARM INPUT & OUTPUT PRIVATE LIMITED aims to improve market access and streamline the agricultural exchange process.

Criaterra Innovations specializes in the production of sustainable building materials, specifically designed to replace traditional precast products such as masonry blocks, exterior cladding, and interior surfaces. Their innovative BioGeo Agglomerated Stone technology upcycles 70% of raw materials and significantly reduces energy consumption in the manufacturing process by 90%. The resulting masonry blocks are six times more insulative than conventional concrete blocks, making them an attractive option for green building initiatives aimed at minimizing embodied carbon dioxide emissions and energy use in structures. Criaterra's products, including indoor tiles that have been licensed for industrial-scale production, are developed with affordability in mind, ensuring that there is no additional cost associated with environmentally friendly options. With over 150 projects utilizing their tiles, Criaterra is well-positioned to advance its masonry block technology and further expand its offerings in the sustainable construction market.

Spectalix provides a unique solution for brands looking to regain user engagement on their own digital platforms, such as apps and websites, by offering a white-label user-generated content (UGC) platform. This innovative platform utilizes advanced AI video technology, including background replacement and image segmentation, which allows users to create personalized video content featuring themselves in various scenes, such as alongside sports teams or popular musicians. By enabling users to share these clips on social media, Spectalix transforms them into micro-influencers, helping brands enhance their digital presence. Additionally, the platform incorporates an automated moderation mechanism to ensure brand safety of the content created. This approach allows brands to monetize their digital assets while fostering a deeper connection with their audience.

The robotic smart kitchen revolution Profutech has developed a patent-protected robotic culinary “Smart Kitchen” device, preparing hot, fresh, and nutritious meals, with one automated click. The company is past the POC stage and addresses a market valued at billions.

Convizit Ltd., based in Tel Aviv, Israel, specializes in web analytics software that utilizes AI technology to automatically capture and analyze user interactions on websites and SaaS applications. The platform collects detailed behavioral data with minimal effort required from users, eliminating the need for manual coding or tagging of events. By enriching this data with relevant properties, Convizit delivers a comprehensive stream of user behavior information directly to various analytics, marketing, and customer data platforms. This approach allows businesses to access reliable behavioral insights quickly, without the traditional challenges of data collection, which can be time-consuming and prone to inaccuracies. Convizit aims to transform the way organizations leverage behavioral data, enabling them to enhance analytics, business intelligence, and personalization efforts effortlessly. The company is actively expanding its team of developers and data scientists to further innovate within the digital analytics space.

Heurobotics researchers will further evolve the Mark II technology. “Heurobotics will be using the Agrowing company’s proprietary sensor technology to perform both remote and close sensing in the field to identify crop stress,” explained Kerry Karl, Heurobotics’ chief executive officer. “Agrowing’s team will work with Heurobotics engineers to develop optimal flight-profile requirements of a small unmanned aerial system of their configuration to collect meaningful data.”

MedAware Ltd specializes in developing solutions aimed at detecting and eliminating prescription errors to enhance patient safety and reduce healthcare costs. Founded in 2012 and headquartered in Raanana, Israel, the company utilizes advanced data analytics and machine learning algorithms to analyze extensive electronic medical records. Its offerings include the MedAS alerting system for real-time alerts on prescription errors, MedRIM for risk management support, MedQC for quality control assistance, and MedRAF to reduce alert fatigue. These tools enable healthcare providers, pharmacy benefit management companies, and pharmacy chains to leverage big data effectively, identify potential prescription errors related to drug interactions, dosages, and allergies, and ultimately improve patient outcomes.

Sanolla is a digital healthcare platform focused on creating innovative medical diagnostic solutions for healthcare professionals and patients. The company specializes in AI-powered diagnostic equipment that analyzes previously inaccessible body infrasounds and vital signs, facilitating the early assessment and monitoring of cardiopulmonary conditions. Sanolla's products are designed to be affordable and user-friendly, promoting non-invasive assessments that enable immediate and accurate diagnostic results. This approach not only enhances patient convenience by reducing unnecessary clinic visits but also minimizes the associated risks of exposure to infections, ultimately saving time and healthcare costs.

Vectorious Medical Technologies Ltd. is a medical device company based in Tel Aviv, Israel, established in 2011. The company specializes in developing and manufacturing advanced cardiac monitoring systems for patients with congestive heart failure. Its flagship product, the V-LAP, is the world's first in-heart microcomputer that provides daily, push-button readings of left atrial pressure (LAP), the earliest and most reliable indicator of heart failure deterioration. This innovative device is miniature, wireless, and battery-less, allowing it to communicate effectively from within the body. Vectorious is currently conducting clinical trials in several European countries, including Italy, Germany, and the UK, aiming to obtain a CE mark for its product. Additionally, plans for a clinical study in the United States were anticipated to commence in 2020. Through its technology, Vectorious aims to enhance the quality of life and life expectancy for individuals suffering from heart failure.

LahakX specializes in agricultural-robotics technology, providing a fleet of autonomous drones designed for efficient crop spraying. The company offers a comprehensive solution that enables growers and applicators to deploy these drones with ease, allowing for precise and sustainable crop protection. Their technology facilitates both uniform coverage of large farm areas and targeted spot spraying, significantly reducing chemical use. By utilizing a modular fleet and advanced software, LahakX enhances operational efficiency, lowers labor and service costs, and improves overall productivity and safety in agricultural practices. Growers can either purchase the complete spraying solution or engage LahakX to provide spraying services, making their value proposition widely accessible. The company's operations in the U.S. commenced earlier this year, marking a significant advancement in agricultural innovation.

Talenya Ltd is a talent sourcing company that operates a technology-driven platform designed to identify and match suitable candidates with job opportunities. Founded in 2016 and based in Rosh Haayin, Israel, with an additional office in Hoboken, New Jersey, Talenya utilizes artificial intelligence and machine learning to gather and analyze data from various online sources. This enables the platform to assess and validate potential candidates, presenting only the most qualified individuals to employers. By automating the recruitment process, Talenya aims to streamline talent sourcing, saving time and increasing the efficiency of matching diverse talent with open positions.

Microbot Medical is a medical device company based in Hingham, Massachusetts, founded in 2010. It specializes in developing micro-robotic technologies for minimally invasive surgery. The company's key products include the Self Cleaning Shunt (SCS) for treating hydrocephalus and normal pressure hydrocephalus, TipCAT, a self-propelling endoscope initially designed for colonoscopy procedures, and Liberty, a combination of guidewire and microcatheter technologies for endoluminal surgery. Microbot Medical aims to enhance surgical outcomes by providing less invasive and more precise solutions, with 37 issued/allowed patents and 15 patent applications pending worldwide.

SoftWheel LTD. is a technology company based in Tel Aviv, Israel, specializing in the development of advanced in-wheel suspension technology for the wheelchair, bicycle, and automotive sectors. Founded in 2011, the company designs innovative suspension systems that absorb shocks and vibrations, enhancing comfort and performance for users, particularly in wheelchairs. SoftWheel's products also contribute to improvements in energy efficiency and overall mobility. The company markets its suspension arms and wheel rims through a network of resellers both in Israel and internationally. To strengthen its position in the market, SoftWheel has established strategic partnerships with notable global firms, including NSK and Linamar.

Yarok Microbio has developed an innovative microbiological testing technology that significantly enhances the speed and accuracy of pathogen detection in the food supply chain and agriculture. The system can identify dangerous microbes such as E. coli, Listeria, Salmonella, and various yeasts and molds within 45 minutes, a substantial improvement over traditional testing methods that take days. This rapid testing capability helps food producers safeguard consumer health, prevent costly product recalls, and mitigate potential legal issues. Additionally, Yarok's technology allows for early detection of plant pathogens, enabling agricultural producers to implement timely phytosanitary measures and reduce pesticide use, thereby minimizing losses of high-value crops. The company's research and development laboratory is located in Jerusalem, Israel, while a demonstration lab in Milan, Italy, supports marketing efforts in Europe. Yarok has been recognized for its contributions to agribusiness innovation, receiving the 2017 Innovation Award from the United Nations Industrial Development Organization and being named one of the top disruptors in the food technology sector by the Institute of Food Technologists in 2019.

City Transformer is an automotive technology company focused on creating innovative solutions for urban mobility. The company has developed an electric city vehicle featuring a patented folding mechanism that allows the car to narrow to just one meter in width. This unique design enables drivers to easily navigate tight traffic and park in spaces typically reserved for motorcycles, significantly enhancing urban parking convenience. The vehicle combines advanced technology, including smart sensors, while prioritizing safety and an improved driving experience. By adapting the car's dimensions and driving behavior, City Transformer addresses the challenges of conventional passenger vehicles, making urban commuting more efficient and accessible.

Lineage Cell Therapeutics is a clinical-stage biotechnology company headquartered in Carlsbad, California, that specializes in the development and commercialization of innovative cellular therapies aimed at addressing unmet medical needs associated with degenerative diseases. The company’s leading product candidates include OpRegen, designed for the treatment of dry age-related macular degeneration, and OPC1, which targets acute spinal cord injuries. Additionally, Lineage is advancing VAC2, an allogeneic cancer immunotherapy aimed at non-small cell lung cancer. Other notable developments include Renevia, a hyaluronan-based hydrogel for treatment of HIV-associated facial lipoatrophy, and HyStem, a biomaterial for cell retention and delivery. Lineage also explores various therapeutic products for oncology and neurological disorders, alongside research programs focused on vision restoration and demyelination. Established in 1990, the company was formerly known as BioTime, Inc., and underwent a rebranding in August 2019.

Gamida Cell is a clinical-stage biopharmaceutical company focused on developing innovative cell therapies for patients with blood cancers and serious hematologic diseases. The company's lead product candidate, omidubicel, is an advanced therapy utilizing nicotinamide-expanded hematopoietic stem cells, currently undergoing Phase 3 trials for patients with high-risk hematologic malignancies and a Phase 1/2 trial for severe aplastic anemia. Additionally, Gamida Cell is advancing GDA-201, a natural killer cell-based immunotherapy that is in Phase 1/2 studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Founded in 1998 and headquartered in Jerusalem, Israel, the company employs a proprietary expansion platform that enhances the properties of nicotinamide to optimize allogeneic cell sources, including umbilical cord blood-derived cells.

BrainStorm Cell Therapeutics Inc. is a biotechnology company focused on developing and commercializing adult stem cell therapies for neurodegenerative diseases. Their proprietary technology, NurOwn, utilizes a patient's own mesenchymal stem cells, which are engineered to produce neurotrophic factors that promote neuronal survival. The company is actively advancing NurOwn through clinical trials for conditions such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Parkinson's disease. Currently, NurOwn is in a Phase III clinical trial for ALS and a Phase II trial for MS, with plans for preclinical studies targeting Parkinson’s disease, Huntington’s disease, and autism spectrum disorder. BrainStorm has partnered with Catalent for the manufacturing of NurOwn, ensuring the production of this autologous cellular therapy. Founded in 2000 and headquartered in New York, BrainStorm Cell Therapeutics was previously known as Golden Hand Resources Inc. before rebranding in 2004.

VBL Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for cancer and immune-inflammatory diseases. The company’s clinical pipeline features two proprietary platform technologies that utilize the body’s natural biological and genetic mechanisms. Their lead product candidate, VB-111, is a gene-based biologic aimed at treating solid tumors, particularly recurrent glioblastoma, an aggressive brain cancer. In addition to its oncology efforts, VBL is also working on therapies for anti-inflammatory conditions through its Lecinoxoid platform technology. The company is dedicated to advancing first-in-class treatments that address significant unmet medical needs.

CYREN Ltd. is a cybersecurity company that specializes in providing cloud-based information security solutions for web, email, and mobile transactions. Founded in 1991 and headquartered in McLean, Virginia, CYREN offers a range of services through its Cyren Cloud Security platform, including Web Security, DNS Security, Email Security, and Cloud Sandboxing, all designed to protect businesses from various cyber threats. The company also provides Cyren Threat Intelligence Services, which include APIs and SDKs for cyber threat detection, as well as advanced endpoint security solutions to combat malware and ransomware. CYREN's global network processes 17 billion transactions daily, safeguarding approximately 600 million users around the world. The company's products are marketed through direct and indirect channels, including value-added resellers and managed service providers, primarily serving enterprise customers and original equipment manufacturers.

TripleW specializes in upcycling food waste into lactic acid, a crucial component for producing polylactic acid (PLA) bioplastics. This innovative approach addresses the growing demand for lactic acid, which is projected to reach $16 billion in the next decade, as it is widely used across various industries. By converting organic waste into valuable bioplastic feedstock, TripleW's technology not only reduces production costs for its clients but also contributes to environmental sustainability by decarbonizing waste. The company's research and development services focus on enhancing bioprocess technology, enabling a circular economy for PLA food and beverage packaging waste, which can be reused to generate additional lactic acid.

AbiliSense Ltd, founded in 2015 and based in Tel Aviv-Yafo, Israel, specializes in sound recognition technology designed to assist individuals with hearing impairments. The company has developed an AI-driven system that enhances Internet of Things (IoT) devices with smart listening capabilities. This technology continuously monitors environmental sounds and can alert users to critical information such as danger, accidents, anomalies, and suspicious activities. Alerts are sent directly to applications, emergency call centers, or various smart devices, ensuring real-time communication of important events. AbiliSense's innovative approach aims to transform auditory signals into actionable insights, thereby improving safety and awareness for those with hearing challenges.

Sanolla is a digital healthcare platform focused on creating innovative medical diagnostic solutions for healthcare professionals and patients. The company specializes in AI-powered diagnostic equipment that analyzes previously inaccessible body infrasounds and vital signs, facilitating the early assessment and monitoring of cardiopulmonary conditions. Sanolla's products are designed to be affordable and user-friendly, promoting non-invasive assessments that enable immediate and accurate diagnostic results. This approach not only enhances patient convenience by reducing unnecessary clinic visits but also minimizes the associated risks of exposure to infections, ultimately saving time and healthcare costs.

FlyWorks Ltd., founded in 2019 and based in Beer-Sheva, Israel, specializes in developing a drone multirotor platform featuring a hybrid propulsion system designed for extended flight durations. The company’s innovative technology integrates a single internal combustion engine with small electric motors, allowing drones to carry significant payloads while maintaining a lightweight structure. This approach not only enhances performance but also ensures safety and cost-effectiveness. FlyWorks' patent-pending drive technology is versatile enough to be adapted for various drone sizes and applications, including land surveying and air-taxi services. By enabling high-resolution, multi-sensor inspections of large-scale power line infrastructure, FlyWorks aims to revolutionize the capabilities of commercial drones in multiple industries.

Since 2012 Reduxio has redefined data management and data protection, and the company has evolved its mission to deliver the first microservices-based storage and data platform for stateful applications. Reduxio’s cloud data platform for Kubernetes pairs high performance software-defined container-native storage and data management with data mobility to enable customers to build a single data cloud for their applications across all their infrastructure, anywhere. Reduxio is backed by Intel Capital, C5 Capital Cloud Partners and Jerusalem Venture Partners (JVP).

TuneFork develops audio personalization technology software aimed at enhancing the hearing experience for users. The software enables individuals to conduct a straightforward hearing test that generates a unique Audio Profile based on their specific hearing characteristics. This profile is used to adjust sound output, ensuring that users receive a tailored audio experience that compensates for their hearing capabilities. The technology can be integrated into various devices, including smartphones, smart TVs, and other IoT devices, optimizing audio across different content types such as phone calls, music, and video. With a focus on accuracy, TuneFork's self-test is clinically validated and provides reliable results, setting a high standard for audio personalization. The company's software-only solution, supported by two patent applications, addresses the diverse needs of users, from those with hearing impairments to those seeking enhanced audio quality.

Amplio is the first and only Impact Platform for Special Education. We are on a mission to help students with special learning needs reach their full potential. The Amplio Platform including research and evidence-based curricula and programs is designed to deliver intensive, rigorous instruction to prepare students for success, both academically and in their everyday lives. Our solutions are developed in conjunction with parents and a world- class advisory council, academics, and school administrators with expertise in special populations. Tens of thousands of students have received services and interventions using the Amplio platform since the solution was launched in 2019.

Lineage Cell Therapeutics is a clinical-stage biotechnology company headquartered in Carlsbad, California, that specializes in the development and commercialization of innovative cellular therapies aimed at addressing unmet medical needs associated with degenerative diseases. The company’s leading product candidates include OpRegen, designed for the treatment of dry age-related macular degeneration, and OPC1, which targets acute spinal cord injuries. Additionally, Lineage is advancing VAC2, an allogeneic cancer immunotherapy aimed at non-small cell lung cancer. Other notable developments include Renevia, a hyaluronan-based hydrogel for treatment of HIV-associated facial lipoatrophy, and HyStem, a biomaterial for cell retention and delivery. Lineage also explores various therapeutic products for oncology and neurological disorders, alongside research programs focused on vision restoration and demyelination. Established in 1990, the company was formerly known as BioTime, Inc., and underwent a rebranding in August 2019.

Gamida Cell is a clinical-stage biopharmaceutical company focused on developing innovative cell therapies for patients with blood cancers and serious hematologic diseases. The company's lead product candidate, omidubicel, is an advanced therapy utilizing nicotinamide-expanded hematopoietic stem cells, currently undergoing Phase 3 trials for patients with high-risk hematologic malignancies and a Phase 1/2 trial for severe aplastic anemia. Additionally, Gamida Cell is advancing GDA-201, a natural killer cell-based immunotherapy that is in Phase 1/2 studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Founded in 1998 and headquartered in Jerusalem, Israel, the company employs a proprietary expansion platform that enhances the properties of nicotinamide to optimize allogeneic cell sources, including umbilical cord blood-derived cells.

Nanofabrica, founded in 2016 and based in Tel Aviv, Israel, specializes in advanced 3D printing technology for precision manufacturing. The company focuses on micro and nanomanufacturing, providing solutions for sectors such as robotics, semiconductors, optics, and medical devices. Its innovative Micro Adaptive Projection technology allows for the production of ultra-precise parts with micron-resolution, enabling the creation of complex designs at competitive prices. By integrating semiconductor lithography and advanced optics within its 3D printing processes, Nanofabrica offers a unique capability to meet the demands of mass customization and rapid production. The company actively seeks customer feedback to refine its technology and tackle new challenges, positioning itself as a leader in the evolving landscape of additive manufacturing.

odix specializes in developing advanced anti-malware tools that utilize Content Disarm and Reconstruction (CDR) technology to enhance cybersecurity for enterprises of all sizes. The company's innovative approach effectively prevents malware infiltration by disarming malicious code embedded within various commonly used file types. By employing unique deep file analysis techniques and patented algorithms, odix's solutions address vulnerabilities that traditional security measures often overlook, providing organizations with robust protection against file-based cyber-attacks. This proactive methodology enables clients to safeguard their networks and ensure a secure digital environment.

Oxitone is a medical technology company specializing in remote patient monitoring. It offers a wearable pulse oximetry device that continuously tracks vital signs, replacing the need for uncomfortable fingertip probes. Powered by AI-aided analytics, Oxitone's platform generates and utilizes continuous medical data to provide personalized, effective therapeutic interventions. The company caters to home care providers seeking efficient alternatives to sporadic remote care of high-risk patients, with its solutions deployed in over 10 countries and generating revenue. Notably, Oxitone has partnered with Ascom for monitoring COVID-19 patients.

CardiacSense Ltd. is an Israeli company founded in 2012, specializing in the development of medical wearable devices aimed at monitoring heart arrhythmias and other critical health metrics. The company offers FDA and CE certified medical watches and wristbands that provide continuous, long-term, non-invasive monitoring of vital signs, including heart rate, respiratory rate, core temperature, oxygen saturation, and blood pressure. Utilizing advanced photoplethysmography (PPG) technology, CardiacSense's devices enable real-time diagnostics for various medical conditions, including atrial fibrillation, hypertension, chronic obstructive pulmonary disease (COPD), heart failure, sleep apnea, and infections such as COVID-19. By focusing on affordability and comfort, CardiacSense aims to enhance patient care and preventative measures within the healthcare industry.